BioLASCO Taiwan Co (ROCO:6662) Total Stockholders Equity : NT$458.3 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co Total Stockholders Equity?

BioLASCO Taiwan Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was NT$458.3 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioLASCO Taiwan Co's Book Value per Share for the quarter that ended in Mar. 2024 was NT$17.89. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioLASCO Taiwan Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.13.

BioLASCO Taiwan Co Total Stockholders Equity Historical Data

The historical data trend for BioLASCO Taiwan Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co Total Stockholders Equity Chart

BioLASCO Taiwan Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

467.24

467.79

460.36

454.64

461.16

BioLASCO Taiwan Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															468.74	439.93	446.87	461.16	458.29

BioLASCO Taiwan Co (ROCO:6662) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioLASCO Taiwan Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(458.287	-	0)	/	25.612
	=	17.89

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioLASCO Taiwan Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(7.441	+	50.769)	/	458.287
	=	0.13

BioLASCO Taiwan Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLASCO Taiwan Co (ROCO:6662) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115

Website

http://www.biolasco.com.tw

BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co (ROCO:6662) Headlines

No Headlines